Measurement and Classification of Neurocognitive Disability in HIV/AIDS Robert K. Heaton Ph.D University of California San Diego Ancient History

Similar documents
The Association Between Comorbidities and Neurocognitive Impairment in Aging Veterans with HIV

Issues of Neuropsychological Assessment in International Settings

International Symposium on. Barcelona, May 5 th and 6 th 2011

The Impact of HIV-Associated Neuropsychological Impairment on Everyday Functioning

Detecting neurocognitive impairment in HIV-infected youth: Are we focusing on the wrong factors?

International Forum on HIV and Rehabilitation Research

HAND is Common and Important in Patients on ART

Neurocognitive Impairments in HIV: Natural History, Impacts on Everyday Functioning and Promising Interventions

Definitional Criteria Working Group 1: Toward an Updated Nosology for HIVassociated Neurocognitive Disorders

The Influence of Sleep on Cognition in Breast Cancer

Neuropsychological Evaluation of

Everyday Problem Solving and Instrumental Activities of Daily Living: Support for Domain Specificity

Overview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?

Meniere s Disease Case. Suzanne Beason-Hazen, Ph.D.

How to Implement this Assessment in the Clinical Prac5ce?

M P---- Ph.D. Clinical Psychologist / Neuropsychologist

TOPF (Test of Pre-Morbid Function)

Improving the Methodology for Assessing Mild Cognitive Impairment Across the Lifespan

Cognitive Impairment and Magnetic Resonance Changes in Multiple Sclerosis. Background

CRITICALLY APPRAISED PAPER

THE INFLUENCE OF CULTURE ON NEUROPSYCHOLOGICAL TESTING IN ZAMBIA

Process of a neuropsychological assessment

Empire BlueCross BlueShield Professional Commercial Reimbursement Policy

Plenary Session 2 Psychometric Assessment. Ralph H B Benedict, PhD, ABPP-CN Professor of Neurology and Psychiatry SUNY Buffalo

Approach to HIV Associated Neurocognitive disorders (HAND)

(5) Severe Alzheimer s Disease (SEV):

Note: These are abbreviated slides with graphics and other protected content removed for electronic posting purposes with NAPSA.

CRITICALLY APPRAISED PAPER (CAP)

Assessing cognition in ELDERLY drivers

An Initial Validation of Virtual Human Administered Neuropsychological Assessments

Supplementary Online Content

Forget me not: providing care for people living with HIV and dementia (What does the future hold for our elderly HIV patients?)

Neuropsychological Testing (NPT)

Traumatic Brain Injury for VR Counselors Margaret A. Struchen, Ph.D. and Laura M. Ritter, Ph.D., M.P.H.

High rates of asymptomatic neurocognitive impairment are observed in perinatally HIV-infected adolescents

Disclosure : Financial No relevant financial relationship exists. Nonfinancial received partial support for my research from BioGen

CRITICALLY APPRAISED PAPER

The Use of Brief Assessment Batteries in Multiple Sclerosis. History of Cognitive Studies in MS

February 8, Prepared By: Glen M. Doniger, PhD Director of Scientific Development NeuroTrax Corporation

HIV & Women: Neurological Issues

Objectives. The Problem. The Problem. The Problem. Assessing the Older Driver

Interpreting change on the WAIS-III/WMS-III in clinical samples

Carmen Inoa Vazquez, Ph.D., ABPP Clinical Professor NYU School of Medicine Lead Litigation Conference Philadelphia May 19, 2009 Presentation

Korean-VCI Harmonization Standardization- Neuropsychology Protocol (K-VCIHS-NP)

Changes, Challenges and Solutions: Overcoming Cognitive Deficits after TBI Sarah West, Ph.D. Hollee Stamper, LCSW, CBIS

Aging: Tools for Assessment

Continuum of Care: Post Acute Brain Injury Rehabilitation

The ABCs of Dementia Diagnosis

Vocational Outcomes of State Voc Rehab Clients with TBI M OMBIS

Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives

Multiple sclerosis : how cognitive performance relates to quality of life, depression, and perception of deficits

Client/Testing Information

COGNITIVE REHABILITATION OF INDIVIDUALS WITH MS CMSC 2015

Neuropsychological Testing in Occupational Medicine

Learning objectives 6/20/2018

Neuropsychological Correlates of Performance Based Functional Status in Elder Adult Protective Services Referrals for Capacity Assessments

NEUROPSYCHOLOGICAL ASSESSMENT S A R A H R A S K I N, P H D, A B P P S A R A H B U L L A R D, P H D, A B P P

Table 1: Summary of measures of cognitive fatigability operationalised in existing research.

CRITICALLY APPRAISED PAPER (CAP)

DSM-5 MAJOR AND MILD NEUROCOGNITIVE DISORDERS (PAGE 602)

Lambros Messinis PhD. Neuropsychology Section, Department of Neurology, University of Patras Medical School

Demystifying the Neuropsychological Evaluation Report. Clinical Neuropsychologist 17 March 2017 Program Director, Neurobehavioral Program

REPORT OF NEUROPSYCHOLOGICAL ASSESSMENT

Use a diagnostic neuropsychology HOW TO DO IT PRACTICAL NEUROLOGY

DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER

Cognitive-Motor Interference in Persons with Parkinson Disease

Cognitive Assessment 4/29/2015. Learning Objectives To be able to:

Can aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators

Alzheimer s Disease and Related Disorders: The Public Health Call to Action

Method. NeuRA Schizophrenia and bipolar disorder April 2016

CLINICAL NEUROPSYCHOLOGY PSYC32

The Neuropsychology of

Functional Assessment Janice E. Knoefel, MD, MPH Professor of Medicine & Neurology University of New Mexico

21/05/2018. Today s webinar will answer. Presented by: Valorie O Keefe Consultant Psychologist

Brain-based disorders in children, teens, and young adults: When to know there is a problem and what to do

MOS SF-36 health survey (Ware &

Cognitive Impairment and Driving:

Driving and Dementia. By Alison Morris OT.

Comprehensive Geriatric Assessment (CGA) Alison A. Moore, MD, MPH UC San Diego Division of Geriatrics and Gerontology

Older Driver at Risk: What do I do?

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

9/8/2017 OBJECTIVES:

Evaluating Functional Status in Hospitalized Geriatric Patients. UCLA-Santa Monica Geriatric Medicine Didactic Lecture Series

What s Wrong With My Client: Understanding Psychological Testing in Order to Work Effectively With Your Expert

Serial 7s and Alphabet Backwards as Brief Measures of Information Processing Speed

Assessing cognitive function after stroke. Glyn Humphreys

HIV-Associated Neurocognitive Disorders (HAND) Aroonsiri Sangarlangkarn, MD, MPH, Jonathan S. Appelbaum, MD, FACP

HIV DISEASE! Neurobehavioral! Neuromedical. Igor Grant, MD, FRCP(C) Director HIV Neurobehavioral Research Program University of California, San Diego

CALIFORNIA STATE UNIVERSITY, NORTHRIDGE APATHY AND DEPRESSION AS PREDICTORS OF NEUROCOGNITVE

THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME

The Role of Cardiovascular Risk and Aging in Memory Performance in a Sample of Veterans with HIV

CRITICALLY APPRAISED PAPER (CAP)

Post-Stroke Targeted Evaluation. Jon Van Doren, Ph.D. Arizona Neuropsychology, PC Scottsdale, AZ

Quality ID #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

DSM-5 and HAND. Diagnosis and Monitoring of HAND 10/6/2015. APA Institute on Psychiatric Services New York City

CommonKnowledge. Pacific University. Stefanie Fendrick Pacific University. Recommended Citation. Notice to Readers

Overview of Cognitive Effects of Pediatric TBI

A multimodal model for the prediction of driving behavior

COGNITIVE FUNCTIONING IN ADULTS AGING WITH HIV: EXPLORING COGNITIVE SUBTYPES AND INFLUENTIAL FACTORS PARIYA L. FAZELI

Rapidly-administered short forms of the Wechsler Adult Intelligence Scale 3rd edition

Transcription:

Measurement and Classification of Neurocognitive Disability in HIV/AIDS Robert K. Heaton Ph.D University of California San Diego Ancient History

Group Means for NP and MMPI Variables N=381 Consecutive referrals for NP testing (1978) Employment: Full-time n = 171 Part-time n = 40 Unemployed n = 170 PIQ 107.3 103.2 96.5 AIR 1.11 1.26 1.84 Trails B 80.9 93.0 152.0 MMPI-Hs 54.8 64.5 68.2 MMPI-D 59.8 67.3 74.7 MMPI-Sc 57.8 70.3 75.0 Classification Accuracy Base Sample 85% Crossvalidatio n 82% Background of HAND Definitions In 1991, the AIDS Task Force of the American Academy of Neurology (AAN) published» Nomenclature and research case definitions to guide the diagnosis of neurological manifestations of HIV-1 infection 16 years later, NIMH & NINDS charged an international working group to critically review the adequacy and utility of these definitional criteria and to identify aspects that require updating. This led to

HIV ASSOCIATED NEUROCOGNITIVE DISORDERS (HAND Criteria) ASYMPTOMATIC NEUROPSYCHOLOGICAL IMPAIRMENT (ANI) MILD NEUROCOGNITIVE DISORDER (MND) HIV-ASSOCIATED DEMENTIA (HAD) NEUROCOGNITIVE IMPAIRMENT > Mild > Mild > Moderate FUNCTIONAL IMPAIRMENT None > Mild > Moderate Impairment must be attributed to HIV, at least in part. Minimal or Moderate comorbidities are OK, but Severe conditions preclude diagnosis of HAND in baseline evaluations. Frascati Definition of Neuropsychological Impairment At least mild impairment in at least 2 ability domains Mild: > 1 SD below mean on demographically corrected scores in > 2 ability domains Moderate-Severe: > 2 SD below mean on > 2 ability domains, or > 2.5 sd below mean on one domain and at least > 1 SD on another domain

Example NP Test Battery Verbal Fluency Category Fluency (Animals) Letter Fluency Executive Functions Category Test computer version Wisconsin Card Sorting Test (64 item version) Trail Making Test Part B Stroop Interference Ratio Attention/Working Memory Paced Auditory Serial Addition Test WAIS-III Letter Number Cognitive Speed Trail Making Test Part A WAIS-III Digit Symbol WAIS-III Symbol Search Stroop Color Naming Learning and Memory (2 domains) Hopkins Verbal Learning Test Rev Brief Visuospatial Memory Test Rev Story Learning and Memory Figure Learning and Memory 1997 The Psychological Corporation. Why Demographic Corrections? : Examples from WAIS-III/ WMS-III

WAIS-III/WMS-III Factor Score Composition Primary Scores Verbal Comprehension Information Vocabulary Similarities Perceptual Organization Block Design Picture Completion Matrix Reasoning Working Memory Spatial Span Letter-Number Sequencing Processing Speed Digit Symbol Symbol Search Auditory Memory Logical Memory I and II Visual Memory Verbal Paired Associates Family Pictures I and I and II II Visual Reproductions I and II 1997 The Psychological Corporation. All Rights Reserved Subject Samples WAIS-III WMS-III N 2312 1073 Age 51 51 Education 12 12 Sex (% Male) 46.5 46.9 Ethnicity (% White) 75.8 73.6 (% African American)13.0 13.8 (% Hispanic) 7.7 8.9 (% Other) 3.5 4.5 FSIQ 99 91.1 1997 The Psychological Corporation.

Verbal Comprehension Factor Verbal Comprehension Education Corrected Z-Score 1.5 1.0 0.5 0.0-0.5-1.0-1.5 R 2 = <0.01 20 25 30 35 40 45 50 55 60 65 70 75 80 85 Age Perceptual Organization Factor Perceptual Organization Education Corrected Z-Score 1.5 1.0 0.5 0.0-0.5-1.0-1.5 R 2 = 0.27 20 25 30 35 40 45 50 55 60 65 70 75 80 85 Age

Processing Speed Factor Processing Speed Factor Education Corrected Z-Score 1.5 1.0 0.5 0.0-0.5-1.0-1.5 R 2 = 0.45 20 25 30 35 40 45 50 55 60 65 70 75 80 85 Age Working Memory Factor Working Memory Factor Education Corrected Z-Score 1.5 1.0 0.5 0.0-0.5-1.0-1.5 R 2 = 0.24 20 25 30 35 40 45 50 55 60 65 70 75 80 85 Age

Auditory Memory Factor Auditory Memory Factor Education Corrected Z-Score 1.5 1.0 0.5 0.0-0.5-1.0-1.5 R 2 = 0.20 20 25 30 35 40 45 50 55 60 65 70 75 80 85 Age Visual Memory Factor Visual Memory Factor Education Corrected Z-Score 1.5 1.0 0.5 0.0-0.5-1.0-1.5 R 2 = 0.45 20 25 30 35 40 45 50 55 60 65 70 75 80 85 Age

Percent Misclassified at 1SD for Factor Scores by Education Percent Misclassified 50% 45% 40% 35% 30% 25% 20% 15% 10% 5% 0% VC PO PS Education Level 0-8 9-11 12 13-15 16+ *Based on Age-Corrected Z-Scores 1997 The Psychological Corporation. All Rights Reserved Percent Misclassified at 1SD for Factor Scores by Education Percent Misclassified 50% 45% 40% 35% 30% 25% 20% 15% 10% 5% 0% WM AM VM Education Level 0-8 9-11 12 13-15 16+ *Based on Age-Corrected Z-Scores 1997 The Psychological Corporation. All Rights Reserved

Percent Misclassified at 1SD for Factor Scores by Sex Percent Misclassified 50% 45% 40% 35% 30% 25% 20% 15% 10% 5% 0% VC PO PS Male Female *Based on Age and Education-Corrected Z-Scores 1997 The Psychological Corporation. All Rights Reserved Percent Misclassified at 1SD for Factor Scores by Sex Percent Misclassified 50% 45% 40% 35% 30% 25% 20% 15% 10% 5% 0% WM AM VM Male Female *Based on Age and Education-Corrected Z-Scores 1997 The Psychological Corporation. All Rights Reserved

Percent Misclassified at 1SD for Factor Scores by Ethnicity Percent Misclassified 50% 45% 40% 35% 30% 25% 20% 15% 10% 5% 0% VC PO PS White African-American Hispanic *Based on Age, Education, and Sex-Corrected Z-Scores 1997 The Psychological Corporation. All Rights Reserved Percent Misclassified at 1SD for Factor Scores by Ethnicity Percent Misclassified 50% 45% 40% 35% 30% 25% 20% 15% 10% 5% 0% WM AM VM White African-American Hispanic *Based on Age, Education, and Sex-Corrected Z-Scores 1997 The Psychological Corporation. All Rights Reserved

Frascati Comorbid Conditions MINIMAL: could have minor effects on NP test results, but unlikely to cause even mild global impairment (does not preclude diagnoses of HAND). MODERATE: likely to have at least mild effects on NP test results but unlikely to cause clinically significant global NP impairment by itself (does not preclude diagnoses of HAND). SEVERE: likely to have major effects on NP test results, with significant neurocognitive impairment and functional disability, or NP results invalid due to poor effort (precludes diagnoses of HAND at baseline assessment). Frascati guidelines for classifying confounds to HAND Depression History of remote traumatic brain injury (TBI) History of developmental disability (cognitive / academic) History of alcohol or other substance use disorder HIV-related opportunistic CNS disease Non-HIV-related Neurologic Condition Systemic disease Co-infection with Hepatitis-C Virus (HCV)

CHARTER Comorbidity Group Comparis Minimal 843 (54%) Moderate 473 (31%) Severe 239 (15%) % Impaired 41% 59% 84% % Employed 33.0% 19.7% 13.0% Depression (BDI) Cognitive Symptoms (PAOFI) IADL Declines 12.3 (10.0) 4.9 (6.3) 1.3 (1.8) 15.7 (11.1) 16.5 (11.9) 7.4 (8.0) 9.3 (9.0) 1.9 (2.1) 2.1 (2.3) Min>Mod> Sev Min>Mod, Sev Min<Mod, Sev Min<Mod< Sev Min<Mod, Sev Mild Functional Decline Requires at least two of the following that are not readily attributable to comorbid conditions in the judgment of the examiner: a) Self report or other report of some increased assistance needed with at least two IADLs such as medication management, financial management, shopping, meal preparation, light housekeeping, laundry, driving, use of public transportation, maintaining personal schedules, understanding media events, and child care. (More IADLs could be considered as appropriate to the individual.) (b) Patient is unable to perform some aspects of a previous job. This is not due to medical symptoms. (c) Although patient may maintain employment and/or full IADL independence, he/she reports less efficiency, reduced productivity, more (d) In the absence of significant depression (e.g., Beck Depression Inventory, > 17, which may bias reporting of symptoms, patient reports that he/she is experiencing increased difficulty with >2 aspects of cognition in daily life. These may include difficulties with memory for recent events (people, conversations, names, commitments, where things are placed, etc.), understanding conversations or reading materials, word finding, planning activities, problem solving, concentrating, thinking clearly or logically, finding his/her way about, calculating, following directions or instructions, etc. Reports of these difficulties also may be obtained from a knowledgeable informant.

Major Functional Decline Requires two or more of the following, that are not readily attributable to medical or other comorbid conditions in the judgment of the examiner : (a) Patient is unable to maintain former employment and this is not due to systemic illness or other factors not related to cognitive impairment (e.g., healthcare coverage being dependent upon disability status). (b) Patient requires substantially greater assistance (or is dependent) with more than two IADLs, as listed above. (c) Patient or a knowledgeable informant reports that he/she experiences/shows significantly greater difficulty with >4 aspects of cognition, as listed above. However, self report is not sufficient (would need confirmation by another informant) if patient is significantly depressed (e.g., BDI>17). (d) If performance-based, standardized functional tasks are administered, patient scores >2 SD below i t ti Approaches to Measuring Everyday Functioning Self-report Proxy (e.g., confidant, caregiver) Direct observation Performance-based measures

Effects of HIV-Related Brain Dysfunction on Everyday Functioning HIV+ Brain Cognitive Impairmen t NP Testing Impaired Performance of Daily Tasks Work Samples Financial Mgt. Tasks Cooking Task Restaurant Task Shopping Task Medication Mgt. Tasks Driving Simulator Poor Life Functioning Symptoms (complaints) Unemployment ADL dependence Poor Medication Adherence Poor driving record 50 40 30 20 NP Impairment and Employment UNEMPLOYED 27 18 DECREASED WORK PERFORMANCE 30 30 10 10 8 6 4 0 NP Normal NP Impaired NP Normal NP Impaired All Subjects Subjects without Medical Disability Heaton et al., 1994

Functional Impact Study (N=282 HIV+) Refine laboratory measures of everyday functioning Determine the relationships among NP status, laboratory ADL measures, and measures of life functioning Identify everyday functioning measures that have utility for treatment outcome assessment Total Cognitive Complaints by NP Status 12 10 Total Complaints 8 6 4 2 p < 0.0001 0 NP Normal NP Impaired

Laboratory Measures of Activities of Daily Living Finances (budget, pay bills, manage checkbook) Shopping (from memory and with list) Meal Planning and Preparation Restaurant Scenario Medication Management Standardized Work Samples Percent Failed Activities of Daily Living by NP Status % Failed 60 50 40 30 20 10 NP Normal NP Impaired All p s < 0.01 0 Money Management Household Finances Shopping Cooking RestaurantMedicatio n Managemen t Work Assessment

Cognitive Complaints by Measures of Everyday Functioning 10 9 8 7 6 5 4 3 2 1 0 * p<0.05 ** p<0.0001 Total Complaints * Passed Failed * * * Shopping Meal RestaurantMedication Finances Planning Management ** ** Work Assessmen t % Employed by FDS Status in Non-AIDS Participants 40 Percent Employed 30 20 10 0 FDS Pass (n=199) FDS Fail (n=67) p <.001

Viral Load by FDS Status Passed Failed 4 * * 3 ** Log10 RNA 2 1 * p <.05 ** p <.01 0 CSF Viral Load (n= 264) Plasma Viral Load (n= 268) IADL Dependence Questionnaire: 13 Domains Dependent = Participant gets assistance in 2 domains Mean IADL Scores by Dependency Status Independent (n = 219) 0.6 (0.9) Dependent (n = 43) 6.1 (3.7)

% Getting Assistance in Specific ADL Tasks by Dependency Groups % Receiving Assistance 60 50 40 30 20 10 p <.0001 Independent (n=219) Dependent (n=43) 0 Financial Management Home Repair Laundry Medication Management Transportation Groceries Reading/T V % Getting Assistance in Specific ADL Tasks by Dependency Cont. % Receiving Assistance 60 50 40 30 20 10 p <.0001 Independent (n=219) Dependent (n=43) 0 Shopping Cooking Housekeeping Dressing Bathing Telephone

Predictors of Employment Status in HIV Infection: IADL Independence and Passing Performance-based Vocational Testing (CHARTER) 40 % Employed 30 20 10 0 Independent Dependent Pass Fail IADL Vocational Performance p <.001 NY Study of Return to Work vangorp et al., JINS, 2007, 80-89 118 job seeking HIV+ participants (79% with AIDS) 52% obtained some work during the 2 years followup Best Predictors:» Learning efficiency* (p=.005)» Young age (p=.03)» Shorter unemployment (p=.03)» AIDS status (p=.04) predictor *Only unique

Likelihood of Driving Last Year by FDS Status 100 90 80 Percent 70 60 50 40 30 20 10 0 FDS Pass (n=141) FDS Fail (n=47) p <.001 Self-Reported Decline in Driving Have your driving abilities decreased since becoming infected with HIV? n = 247

Driving Study Procedures A. Neuropsychological Testing B. Driving Simulations (2) C. On-Road Evaluation PC-based Driving Simulator Systems Technology, Inc.

Simulation #1: Advanced Routine and Emergency Driv 12 minute drive City and country driving Straight, curved, and inclined roads Speed limit ranged from 35 mph to 65 mph Subjects must pass cars, stop at traffic lights, drive around stalled vehicles, adjust to fog Accident avoidance: n=5 Primary outcome: Number of accidents Mean Number of Accidents on City Driving 3 Number of Accidents 2 1 1.4 1.2 2.0 0 HIV- HIV+ Normal HIV+ Impaired Diagnosis

Simulation #2: Virtual City Virtual City Number of Blocks Beyond Optimal Performance 14 12 Number of Extra Blocks 10 8 6 4 2 3.8 3.9 9.5 0 HIV- HIV+ Normal HIV+ Impaired

On-Road Driving Examination 30 minute evaluation modeled after the California DMV Driving Performance Evaluation (DPE) Assesses: traffic checks speed control lane position merging dangerous maneuvers Residential, business sections; freeway driving; destination task Evaluation completed by driving rehabilitation instructor and trained research assistant On-Road Driving Evaluation Percent Unsafe on the Road 50 40 30 20 10 0 ** 36.4 4.8 6.9 HIV- (n=20) HIV+ NL (n=29) HIV+ Imp (n=11)

Laboratory Predictors of On-Road Driving Performance Variable NP Global Deficit Score.017 Simulator Accidents.029 Virtual City Return Blocks.07 Overall model p <.001 47.6% of on-road variance explained (Education and miles driven in past year differed between groups, but were not significant in the model (p >.30) and were dropped from the model) Impairments in Executive Functioning, Attention/Working Memory were the best predictors of on-road failure Marcotte et al., 2004 p

Percent of Subjects with Neurobehavioral Disorders (n = 975) 60% 50% 1.9% 1.8% % with Disorder 40% 30% 20% 10% 15.1% 0.5% 4.8% 26.5% 18.3% 25.4% 28.3% 17.7% HAD MCMD Subsyndromic 0% HIV- CDC A CDC B CDC C (n=212) (n=437) (n=213) (n=113) Domain-Specific Impairment Rates for HIV+ Subjects Classified as Impaired % Impairment 80 70 60 50 40 30 20 10 0 38 Verbal Fluency 72 Executive Function 54 54 Attn/WM Cognitive Speed 76 Learning 54 51 Delayed Recall Motor Ability Area

Definition of Impairment Categories Conceptual Category T-Score Percentage of Normals Normal > 40 85.4 Mild Imp 35-39 8.6 Mild-Mod Imp 30-34 4.0 Moderate Imp 25-29 1.5 Mod-Sev Imp 20-24 0.4 Severe Imp < 20 0.1